-- CFRA, an independent research provider, has providedwith the following research alert. Analysts at CFRA have summarized their opinion as follows:
We raise our 12-month target to $140 from $90, on a higher revised EV/sales of about 4x our 2027 sales estimate, within peers. We widen our 2026 loss per share (LPS) estimate to $3.14 from $0.41 and revise our 2027 forecast to a LPS of $0.89 from an EPS of $1.69. CRWV posted mixed results, with disappointing revenue guidance for CY 26 and widening losses, as the company looks to grow at all costs. We are impressed by CRWV's ability to sign strategic deals with OpenAI, Meta, and hyperscalers, though elevated execution risk from its aggressive $31B-$35B capex plan in 2026, coupled with expected negative FCF through decade end and high leverage (debt increased 170% to $21.4B), keeps us on the sidelines. Q1 marked CRWV's strongest bookings period, with backlog surging to $99.4B from $66.8B in Q4. We believe CRWV's ability to pre-sell substantially all 2026 capacity ahead of deployment, with average contract lengths extending to five years and take-or-pay structures, provides exceptional multiyear visibility.